# US 2001/0027200 A1 · PPARgamma modulators

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0027200 A1
- Document ID: US20010027200A1
- Status: Published application
- Kind: A1
- Application number: 09/741,415
- Filed: 2000-12-19
- Published: 2001-10-04
- Earliest claimed: 1998-01-29
- Assignees: Tularik Inc.
- Inventors: Fabienne De la Brouse-Elwood; Jin-Long Chen; Timothy D. Cushing; John A. Flygare; Jonathan B. Houze; Juan C. Jaen; Lawrence R. McGee; Shi-Chang Miao; Steven Marc Rubenstein; Patrick C. Kearney
- Web page: https://patentgrep.com/patent/US20010027200A1

## CPC

- C07D 213/70: Sulfur atoms
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07C 311/21: having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07D 213/65: attached in position 3 or 5
- C07D 215/20: Oxygen atoms
- C07D 217/04: with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
- C07D 405/12: linked by a chain containing hetero atoms as chain links
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

Modulators of PPARγ activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity.

## Claims

### Claim 1

A compound having the formula: 57
wherein
Ar1 is an aryl group;
X is a divalent linkage selected from the group consisting of (C1-C6)alkylene, (C1-C6)alkylenoxy, —O—, —C(O)—, —N(R11)-, —N(R11)C(O)—, —S(O)k— and a single bond,
wherein
R11 is a member selected from the group consisting of hydrogen, alkyl, heteroalkyl and arylalkyl; and the subscript k is an integer of from 0 to 2;
Y is a divalent linkage selected from the group consisting of alkylene, —O—, —C(O)—, —N(R12)-S(O)m—, N(R12)-S(O)m—N(R13)-, —N(R12)C(O)—, —S(O)n— and a single bond,
wherein
R12 and R13 are members independently selected from the group consisting of hydrogen, alkyl, heteroalkyl and arylalkyl; and the subscripts m and n are independently integers of from 0 to 2;
R1 is a member selected from the group consisting of hydrogen, alkyl, heteroalkyl, aryl, arylalkyl, —C(O)R14, —CO2R14, —C(O)NR15R16, —S(O)P-R14 —S(O)q—NR15R16, —O—C(O)—OR17, —O—C(O)-R′, —O—C(O)-NR15R16, —N(R14)-C(O)—NR15R16, —N(R14)-C(O)-R17 and —N(R14)-C(O)—OR17;
wherein
R14 is a member selected from the group consisting of hydrogen, alkyl, heteroalkyl, aryl and arylalkyl;
R15 and R16 are members independently selected from the group consisting of hydrogen, alkyl, heteroalkyl, aryl, and arylalkyl, or taken together with the nitrogen to which each is attached form a 5-, 6- or 7-membered ring;
R17 is a member selected from the group consisting of alkyl, heteroalkyl,aryl and arylalkyl;
the subscript p is an integer of from 0 to 3; and
the subscript q is an integer of from 1 to 2; and
R2 is a member selected from the group consisting of alkyl, heteroalkyl, aryl and arylalkyl
with the proviso that when Ar1-X- is 5-chloro-3-pyridyloxy, R1 is carboethoxy and Y is —NHSO2—, and the groups Ar1-X-, R1 and -Y-R2 occupy positions at carbons 2, 1 and 5 of the benzene ring, respectively, then R2 is other than 4-tolyl or 2,4-dichloro-5-methylphenyl.

### Claim 2 (depends on 1)

A compound of claim 1, wherein Ar1 is a heteroaryl group having from 1 to 3 nitrogen atoms as ring members.

### Claim 3 (depends on 1)

A compound of claim 1, wherein X is a divalent linkage selected from the group consisting of —O—, —C(O)—, —N(R11)-, —S— and a single bond, and R11 is hydrogen or (C1-C8)alkyl.

### Claim 4 (depends on 1)

A compound of claim 1, wherein Y is a divalent linkage selected from the group consisting of —N(R12)-S(O)2—, —N(R12)-S(O)2—N(R13)-, —S(O)2— and —S(O)—; and R12 and R13 are independently selected from the group consisting of hydrogen and (C1-C8)alkyl, and R2 is a member selected from the group consisting of aryl and arylalkyl.

### Claim 5 (depends on 1)

A compound of claim 1, wherein R1 is selected from the group consisting of hydrogen, aryl, —CO2R14, —C(O)NR15R16, —N(R14)-C(O)-R′, —N(R14)-C(O)—OR1 and —O—C(O)-R17; R14 is selected from the group consisting of alkyl and arylalkyl; R15 and R16 are independently selected from the group consisting of hydrogen and alkyl, or taken together with the nitrogen to which each is attached form a 5- or 6-membered ring; and R17 is selected from the group consisting of alkyl and arylalkyl.

### Claim 6 (depends on 1)

A compound of claim 1, wherein Ar1 is a mono- or bicyclic heteroaryl group having from 1 to 2 nitrogen atoms as ring members.

### Claim 7 (depends on 6)

A compound of claim 6, wherein Ar1 is substituted with from one to two substituents selected from the group consisting of halogen, —OCF3, —OH, —O(C1-C6)alkyl, —CF3, (C1-C8)alkyl and —NO2.

### Claim 8 (depends on 7)

A compound of claim 7, wherein Ar1 is a monocyclic heteroaryl group having a single substituent selected from the group consisting of halogen, —OCF3 and —CF3.

### Claim 9 (depends on 1)

A compound of claim 1, wherein said compound is represented by a formula selected from the group consisting of 58

### Claim 10 (depends on 9)

A compound of claim 9, wherein Ar1 is a monocyclic heteroaryl group having from 1 to 2 nitrogen atoms as ring members and being mono-substituted by halogen or —CF3.

### Claim 11 (depends on 1)

A compound of claim 1, wherein X is a divalent linkage selected from the group .consisting of —O—, —S—, —NH— and a single bond.

### Claim 12 (depends on 1)

A compound of claim 1, wherein Y is a divalent linkage selected from the group consisting of —NH—S(O)2— and —NH—S(O)2—NH—; and R2 is aryl.

### Claim 13 (depends on 1)

A compound of claim 1, wherein R1 is selected from the group consisting of —H, —(C1-C8)alkyl, —CONR15R16 and aryl having from 1 to 3 heteroatoms as ring members; and R13 and R16 are each independently selected from H, alkyl, aryl and arylalkyl.

### Claim 14 (depends on 13)

A compound of claim 13, wherein R1 is an aryl group selected from 59
wherein
R18 is a member selected from the group consisting of hydrogen, (C1-C8)alkyl, unsubstituted aryl, —OR19, —SR19 and —NR20R21,
wherein
R19 is H or (C1-C8)alkyl; and
R20 and R21 are independently selected from the group consisting of hydrogen and (C1-C8)alkyl, or together with the nitrogen atom to which each is attached, form a 5-, 6-, or 7-membered ring system.

### Claim 15 (depends on 1)

A compound of claim 1, wherein R2 is selected from the group consisting of substituted phenyl, substituted pyridyl and substituted naphthyl, wherein the substituents number from one to three and are independently selected from the group consisting of halogen, —OCF3, —OH, —O(C1-C8)alkyl, —C(O)—(C1-C8)alkyl, —CN, —CF3, (C1-C8)alkyl and —NH2.

### Claim 16 (depends on 1)

A compound of claim 1, wherein R2 is a phenyl ring having from one to three halogen substituents.

### Claim 17 (depends on 1)

A compound of claim 1, selected from the group consisting of 60

### Claim 18 (depends on 1)

A compound of claim 1, selected from the group consisting of 61

### Claim 19 (depends on 1)

A compound of claim 1, selected from the group consisting of 62

### Claim 20 (depends on 1)

A compound of claim 1, selected from the group consisting of 63

### Claim 21 (depends on 1)

A compound of claim 1, selected from the group consisting of 64

### Claim 22 (depends on 1)

A compound of claim 1, selected from the group consisting of 65

### Claim 23 (depends on 1)

A compound of claim 1, selected from the group consisting of 66

### Claim 24 (depends on 1)

A compound of claim 1, selected from the group consisting of 67

### Claim 25 (depends on 1)

A compound of claim 1, having the structure: 68

### Claim 26

A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound having the formula: 69
wherein
Ar1 is an aryl group;
X is a divalent linkage selected from the group consisting of (C1-C6)alkylene, (C1-C6)alkylenoxy, —O—, —C(O)—, —N(R11)-, —N(R11)C(O)—, —S(O)k— and a single bond,
wherein
R11 is a member selected from the group consisting of hydrogen, alkyl, heteroalkyl and arylalkyl; and the subscript k is an integer of from 0 to 2;
Y is a divalent linkage selected from the group consisting of alkylene, —O—, —C(O)—, —N(R12)-S(O)m—, —N(R12)—S(O)m—N(R13)-, —N(R12)C(O)—, —S(O)n— and a single bond,
wherein
R12 and R13 are members independently selected from the group consisting of hydrogen, alkyl, heteroalkyl and arylalkyl; and the subscripts m and n are independently integers of from 0 to 2;
R1 is a member selected from the group consisting of hydrogen, alkyl, heteroalkyl, aryl, arylalkyl, —C(O)R14, —CO2R14, —C(O)NR15R16, S(O)p-R14, —S(O)q—NR15R16, —O—C(O)—OR17, —O—C(O)-R17, —C(O)—NR15R16, —N(R14)-C(O)—NR15R16, —N(R4)-C(O)-R17 and —N(R14)-C(O)—OR17;
wherein
R14 is a member selected from the group consisting of hydrogen, alkyl, heteroalkyl, aryl and arylalkyl;
R15 and R16 are members independently selected from the group consisting of hydrogen, alkyl, heteroalkyl, aryl, and arylalkyl, or taken together with the nitrogen to which each is attached form a 5-, 6- or 7-membered ring;
R17 is a member selected from the group consisting of alkyl, heteroalkyl,aryl and arylalkyl;
the subscript p is an integer of from 0 to 3; and
the subscript q is an integer of from 1 to 2; and
R2 is a member selected from the group consisting of alkyl, heteroalkyl, aryl and arylalkyl.

### Claim 27 (depends on 26)

A composition of claim 26, wherein Ar1 is a heteroaryl group having from 1 to 3 nitrogen atoms as ring members.

### Claim 28 (depends on 26)

A composition of claim 26, wherein X is a divalent linkage selected from the group consisting of —O—, —C(O)—, —N(R11)-, —S— and a single bond, and R11 is hydrogen or (C1-C8)alkyl.

### Claim 29 (depends on 26)

A composition of claim 26, wherein Y is a divalent linkage selected from the group consisting of —N(R12)-S(O)2—, —N(R12)-S(O)2—N(R13)-, —S(O)2— and —S(O)—; and R12 and R13 are independently selected from the group consisting of hydrogen and (C1-C8)alkyl, and R2 is a member selected from the group consisting of aryl and arylalkyl.

### Claim 30 (depends on 26)

A composition of claim 26, wherein R1 is selected from the group consisting of hydrogen, aryl, —CO2R14, —C(O)NR15R16, —N(R4)-C(O)-R11, —N(R14)-C(O)—OR17 and —O—C(O)-R17; R14 is selected from the group consisting of alkyl and arylalkyl; R15 and R16 are independently selected from the group consisting of hydrogen and alkyl, or taken together with the nitrogen to which each is attached form a 5- or 6-membered ring; and R17 is selected from the group consisting of alkyl and arylalkyl.

### Claim 31 (depends on 26)

A composition of claim 26, wherein Ar1 is a mono- or bicyclic heteroaryl group having from 1 to 2 nitrogen atoms as ring members.

### Claim 32 (depends on 31)

A composition of claim 31, wherein Ar1 is substituted with from one to two substituents selected from the group consisting of halogen, —OCF3, —OH, —O(C1-C6)alkyl, —CF3, (C1-C8)alkyl and —NO2.

### Claim 33 (depends on 32)

A composition of claim 32, wherein Ar1 is a monocyclic heteroaryl group having a single substituent selected from the group consisting of halogen, —OCF3 and —CF3.

### Claim 34 (depends on 26)

A composition of claim 26, wherein said compound is represented by a formula selected from the group consisting of 70

### Claim 35 (depends on 34)

A composition of claim 34, wherein Ar1 is a monocyclic heteroaryl group having from 1 to 2 nitrogen atoms as ring members and being mono-substituted by halogen or —CF3.

### Claim 36 (depends on 26)

A composition of claim 26, wherein X is a divalent linkage selected from the group consisting of —O—, —S—, —NH— and a single bond.

### Claim 37 (depends on 26)

A composition of claim 26, wherein Y is a divalent linkage selected from the group consisting of —NH—S(O)2— and —NH—S(O)2—NH—; and R2 is aryl.

### Claim 38 (depends on 26)

A composition of claim 26, wherein R1 is selected from the group consisting of —CO2R14 and aryl having from 1 to 3 heteroatoms as ring members; and R14 is a (C1-C8)alkyl.

### Claim 39 (depends on 38)

A composition of claim 38, wherein R1 is an aryl group selected from 71
wherein
R18 is a member selected from the group consisting of hydrogen, (C1-C8)alkyl, unsubstituted aryl, —OR19, —SR19 and —NR20R21,
wherein
R19 is H or (C1-C8)alkyl; and
R20 and R21 are independently selected from the group consisting of hydrogen and (C1-C8)alkyl, or together with the nitrogen atom to which each is attached, form a 5-, 6-, or 7-membered ring system.

### Claim 40 (depends on 26)

A composition of claim 26, wherein R2 is selected from the group consisting of substituted phenyl and substituted naphthyl, wherein the substituents number from one to three and are independently selected from the group consisting of halogen, —OCF3, —OH, —O(C1-C8)alkyl, —CF3, (C1-C8)alkyl and —NH2.

### Claim 41 (depends on 26)

A composition of claim 26, wherein R2 is a phenyl ring having from one to three halogen substituents.

### Claim 42 (depends on 26)

A composition of claim 26, said compound selected from the group consisting of 72

### Claim 43 (depends on 26)

A composition of claim 26, said compound selected from the group consisting of 73

### Claim 44 (depends on 26)

A composition of claim 26, said compound selected from the group consisting of 74

### Claim 45 (depends on 26)

A composition of claim 26, said compound selected from the group consisting of 75

### Claim 46 (depends on 26)

A composition of claim 26, said compound selected from the group consisting of 76

### Claim 47 (depends on 26)

A composition of claim 26, said compound selected from the group consisting of 77

### Claim 48 (depends on 26)

A composition of claim 26, said compound selected from the group consisting of 78

### Claim 49 (depends on 26)

A composition of claim 26, said compound selected from the group consisting of 79

### Claim 50 (depends on 26)

A composition of claim 26, said compound having the structure: 80

### Claim 51 (depends on 26)

A composition of claim 26, said compound having the structure: 81

### Claim 52

A method for modulating conditions associated with metabolic or inflammatory disorders in a host, said method comprising administering to said host an efficacious amount of a compound having the formula: 82
wherein
Ar1 is an aryl group;
X is a divalent linkage selected from the group consisting of (C1-C6)alkylene, (C1-C6)alkylenoxy, —O—, —C(O)—, —N(R11)-, —N(R11)C(O)—, —S(O)k— and a single bond,
wherein
R11 is a member selected from the group consisting of hydrogen, alkyl, heteroalkyl and arylalkyl; and the subscript k is an integer of from 0 to 2;
Y is a divalent linkage selected from the group consisting of alkylene, —O—, —C(O)—, —N(R12)-S(O)m—, N(R12)-S(O)m—N(R13)-, —N(R12)C(O)—, —S(O)n— and a single bond,
wherein
R12 and R13 are members independently selected from the group consisting of hydrogen, alkyl, heteroalkyl and arylalkyl; and the subscripts m and n are independently integers of from 0 to 2;
R1 is a member selected from the group consisting of hydrogen, alkyl, heteroalkyl, aryl, arylalkyl, —C(O)R14, —CO2R14, —C(O)NR15R16, —S(O)p-R14, —S(O)q—NR15R16, —O—C(O)—OR17, —O—C(O)-R17, —O—C(O)—NR15R16, —N(R14)-C(O)—NR15R16, —N(R14)-C(O)-R17 and —N(R14)-C(O)—OR17;
wherein
R14 is a member selected from the group consisting of hydrogen, alkyl, heteroalkyl, aryl and arylalkyl;
R15 and R16 are members independently selected from the group consisting of hydrogen, alkyl, heteroalkyl, aryl, and arylalkyl, or taken together with the nitrogen to which each is attached form a 5-, 6- or 7-membered ring;
R17 is a member selected from the group consisting of alkyl, heteroalkyl,aryl and arylalkyl;
the subscript p is an integer of from 0 to 3; and
the subscript q is an integer of from 1 to 2; and
R2 is a member selected from the group consisting of alkyl, heteroalkyl, aryl and arylalkyl.

### Claim 53 (depends on 52)

A method in accordance with claim 52, wherein Ar1 is a heteroaryl group having from 1 to 3 nitrogen atoms as ring members.

### Claim 54 (depends on 52)

A method in accordance with claim 52, wherein X is a divalent linkage selected from the group consisting of —O—, —C(O)—, —N(R11)-, —S— and a single bond, and R11 is hydrogen or (C1-C8)alkyl.

### Claim 55 (depends on 52)

A method in accordance with claim 52, wherein Y is a divalent linkage selected from the group consisting of —N(R12)-S(O)2—, —N(R12)-S(O)2—N(R13)-, —S(O)2— and —S(O)—; and R12 and R13 are independently selected from the group consisting of hydrogen and (C1-C8)alkyl, and R2 is a member selected from the group consisting of aryl and arylalkyl.

### Claim 56 (depends on 52)

A method in accordance with claim 52, wherein R1 is selected from the group consisting of hydrogen, aryl, —CO2R14, —C(O)NR15R16, —N(R14)-C(O)-R17, —N(R14)-C(O)—OR17 and —O—C(O)-R17; R14 is selected from the group consisting of alkyl and arylalkyl; R15 and R16 are independently selected from the group consisting of hydrogen and alkyl, or taken together with the nitrogen to which each is attached form a 5- or 6-membered ring; and R17 is selected from the group consisting of alkyl and arylalkyl.

### Claim 57 (depends on 52)

A method in accordance with claim 52, wherein Ar1 is a mono- or bicyclic heteroaryl group having from 1 to 2 nitrogen atoms as ring members.

### Claim 58 (depends on 57)

A method in accordance with claim 57, wherein Ar1 is substituted with from one to two substituents selected from the group consisting of halogen, —OCF3, —OH, —O(C1-C6)alkyl, —CF3, (C1-C8)alkyl and —NO2.

### Claim 59 (depends on 58)

A method in accordance with claim 58, wherein Ar1 is a monocyclic heteroaryl group having a single substituent selected from the group consisting of halogen, —OCF3 and —CF3.

### Claim 60 (depends on 52)

A method in accordance with claim 52, wherein said compound is represented by a formula selected from the group consisting of 83

### Claim 61 (depends on 60)

A method in accordance with claim 60, wherein Ar1 is a monocyclic heteroaryl group having from 1 to 2 nitrogen atoms as ring members and being mono-substituted by halogen, —OCF3 or —CF3.

### Claim 62 (depends on 52)

A method in accordance with claim 52, wherein X is a divalent linkage selected from the group consisting of —O—, —S—, —NH— and a single bond.

### Claim 63 (depends on 52)

A method in accordance with claim 52, wherein Y is a divalent linkage selected from the group consisting of —NH—S(O)2— and —NH—S(O)2—NH—; and R2 is aryl.

### Claim 64 (depends on 52)

A method in accordance with claim 52, wherein R1 is selected from the group consisting of —CO2R14 and aryl having from 1 to 3 heteroatoms as ring members; and R14 is a (C1-C8)alkyl.

### Claim 65 (depends on 64)

A method in accordance with claim 64, wherein R1 is an aryl group selected from 84
wherein
R18 is a member selected from the group consisting of hydrogen, (C1-C8)alkyl, unsubstituted aryl, —OR19, —SR19 and —NR20R21,
wherein
R19 is H or (C1-C8)alkyl; and
R20 and R21 are independently selected from the group consisting of hydrogen and (C1-C8)alkyl, or together with the nitrogen atom to which each is attached, form a 5-, 6-, or 7-membered ring system.

### Claim 66 (depends on 52)

A method in accordance with claim 52, wherein R2 is selected from the group consisting of substituted phenyl and substituted naphthyl, wherein the substituents number from one to three and are independently selected from the group consisting of halogen, —OCF3, —OH, —O(C1-C8)alkyl, —CF3, (C1-C8)alkyl and —NH2.

### Claim 67 (depends on 52)

A method in accordance with claim 52, wherein R2 is a phenyl ring having from one to three halogen substituents.

### Claim 68 (depends on 52)

A method in accordance with claim 52, said compound selected from the group consisting of 85

### Claim 69 (depends on 52)

A method in accordance with claim 52, said compound selected from the group consisting of 86

### Claim 70 (depends on 52)

A method in accordance with claim 52, said compound selected from the group consisting of 87

### Claim 71 (depends on 52)

A method in accordance with claim 52, said compound selected from the group consisting of 88

### Claim 72 (depends on 52)

A method in accordance with claim 52, said compound selected from the group consisting of 89

### Claim 73 (depends on 52)

A method in accordance with claim 52, said compound selected from the group consisting of 90

### Claim 74 (depends on 52)

A method in accordance with claim 52, said compound selected from the group consisting of 91

### Claim 75 (depends on 52)

A method in accordance with claim 52, said compound selected from the group consisting of 92

### Claim 76 (depends on 52)

A method in accordance with claim 52, said compound having the formula: 93

### Claim 77 (depends on 52)

A method in accordance with claim 52, said compound having the formula: 94

### Claim 78 (depends on 52)

A method in accordance with claim 52, wherein said host is a mammal selected from the group consisting of humans, dogs, monkeys, mice, rats, horses and cats.

### Claim 79 (depends on 52)

A method in accordance with claim 52, wherein said administering is oral.

### Claim 80 (depends on 52)

A method in accordance with claim 52, wherein said administering is topical.

### Claim 81 (depends on 52)

A method in accordance with claim 52, wherein said administering is prophylactic to prevent the onset of a PPARγ-mediated condition.

### Claim 82 (depends on 52)

A method in accordance with claim 52, wherein said disorders are selected from the group consisting of NIDDM, obesity and inflammatory conditions.

### Claim 83 (depends on 52)

A method in accordance with claim 52, wherein said administering is parenteral.

### Claim 84 (depends on 52)

A method in accordance with claim 52, wherein said metabolic disorders are mediated by PPARγ.
